AZYP, LLC

Biotech

Superficially porous particle (SPP) based chiral stationary phases (CSPs) for high-performance liquid chromatography

Grants
$1.1M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
2 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Agriculture · Removal Of Isomeric Ballast In Agrochemicals Using An Inulin Based Agro-product$99,925
Federal grantDepartment of Health and Human Services · Phase II · Superficially Porous Silica Based Chiral Stationary Phases for High Efficiency and High Speed Pharmaceutical Analysis and Purification$486,100
Federal grantDepartment of Health and Human Services · Phase II · Superficially Porous Silica Based Chiral Stationary Phases for High Efficiency and High Speed Pharmaceutical Analysis and Purification$486,100
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1797vTv Therapeutics Holdings LLC——
1798Arbor Plastic Technologies, LLC—$910K
1799SUVALENT THERAPEUTICS INC.——
1800AZYP, LLC——
1801MEDIUM ENTERTAINMENT INC—$1.0M
1802Correlate Infrastructure Partners, Inc.—$3.4M
1803Aviceda——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 2 granted of 4

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.